Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ASP1951 |
| Synonyms | |
| Therapy Description |
ASP1951 (PTZ-522) is a tetravalent agonistic antibody that targets GITR, potentially resulting in increased proliferation of tumor infiltrating lymphocytes and enhanced anti-tumor immune response (PMID: 30400822). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ASP1951 | PTZ-522|PTZ522|ASP-1951|ASP 1951 | GITR Antibody 7 | ASP1951 (PTZ-522) is a tetravalent agonistic antibody that targets GITR, potentially resulting in increased proliferation of tumor infiltrating lymphocytes and enhanced anti-tumor immune response (PMID: 30400822). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03799003 | Phase I | ASP1951 | A Study of ASP1951 in Subjects With Advanced Solid Tumors | Terminated | USA | CAN | 2 |